Vice President, Investment Banking – Biopharma/Life Sciences
Moelis & Company (“Moelis”) Open · verified Oct 22, 2026 At a glance
VP-level Investment & Corporate Development role at Moelis & Company (“Moelis”). New York · full-time · $250,000 base.
financeroles summary, based on the employer's posting.
What you'll do
- Assess mechanisms, clinical evidence, development risks and competing assets to judge the value of biopharma programs
- Turn asset assessments into rNPV and other valuation models, forecasts, deal terms and transaction recommendations
- Shape the scientific case in materials and explain it to boards, executives, sponsors and investors
- Move M&A, licensing and financing assignments from identifying targets or partners through diligence, negotiation and closing
- Track clinical catalysts, regulatory developments, competing pipelines and deal activity to generate ideas, while guiding junior deal staff
What you bring
- At least five years in biopharma banking, life sciences investing, licensing, strategy consulting, or a related listed function
- Strong scientific grounding in a therapeutic area or modality, with the ability to evaluate clinical evidence independently
- A record of building and defending asset valuations and forecasts, including rNPV models
- An advanced life sciences degree or an MBA
Who this fits
This New York vice president role suits a scientifically grounded dealmaker who can connect clinical judgment to valuation and client advice. You’ll work with execution bankers and senior bankers, lead and develop Analysts and Associates, and contribute to client relationships and new business.
From the employer
We are passionate about our business and our culture, and are seeking individuals with that same drive.
About Moelis:
Moelis & Company (“Moelis”) is a leading global independent investment bank that provides innovative strategic advice and solutions to a diverse client base, including corporations, governments, and financial sponsors. The Firm assists its clients in achieving their strategic goals by offering comprehensive integrated financial advisory services across all major industry sectors. Moelis’s experienced professionals advise clients on their most critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, secondary transactions and primary fundraising, and other corporate finance matters. The Firm serves clients from locations across North and South America, Europe, the Middle East, and Asia-Pacific. For further information, please visit: www.moelis.com.
The Opportunity:
We are seeking a Vice President to join our Life Sciences team in New York in a science-led seat. This is a role for a dealmaker whose edge is scientific and clinical judgement: you will be a core member of the team who reads the data, forms a view on an asset, and translates that view into valuation, positioning and transaction strategy. You will work alongside execution bankers on biopharma M&A, licensing and partnering, private and public financings, and strategic advisory mandates, and directly with Executive Directors and Managing Directors on client dialogue and origination.
To learn more about our recent transactions, please visit: recent transactions
Responsibilities:
- Lead scientific and clinical diligence on assets and platforms, including mechanism of action, target validation, clinical data assessment, development risk and probability of success, competitive landscape and differentiation
- Translate scientific judgement into commercial and valuation outputs, including risk-adjusted NPV and rNPV models, peak sales and patient-based forecasts, discounted cash flow, comparable company and precedent transaction analysis, and deal structures including milestones and royalties
- Own the scientific narrative in client and investor materials, and present it credibly to boards, management teams, sponsors and institutional investors
- Support M&A, licensing and partnering, and financing mandates end to end, from target and partner identification through diligence, negotiation support and closing
- Track the therapeutic and modality landscape, clinical and regulatory catalysts, competitor pipelines, deal comparables and financing markets, and convert that into origination ideas for the team
- Partner with execution bankers and capital markets colleagues, and lead, review and develop Analysts and Associates on the deal team
- Contribute to business development and relationship building with biopharma corporate development teams, venture and crossover investors and academic and translational partners
Preferred Qualifications:
- 5+ years of relevant experience within biopharma investment banking, equity research, corporate or business development and licensing, life sciences strategy consulting, or venture and crossover investing
- Deep scientific fluency in one or more therapeutic areas or modalities, and the ability to read and interrogate clinical data independently
- Demonstrated ability to build and defend asset-level valuation and forecasting models, including rNPV
- Experience leading and developing deal teams or project teams, and owning the quality of the output
- Credibility and presence with scientific and commercial audiences, from R&D leadership to boards and investors
- Demonstrated maturity, attention to detail, initiative and problem-solving skills, and the ability to adapt to changing client and firm needs
Education:
- Advanced degree in the life sciences (PhD, MD, PharmD or MS) or an MBA.
Expected Salary: $250,000 USD
We are an Equal Opportunity Employer. Applicants are considered for employment opportunities without regard to race, age, religion, color, sex (including pregnancy and gender identity), parental status, national origin, marital status, veteran status, sexual orientation, political affiliation, citizenship status, genetic information (including family medical history), disability (in compliance with the Americans with Disabilities Act and any other applicable law), or any other characteristic or status protected under any applicable US, state or other law. This policy applies to all terms and conditions of employment, including recruitment and hiring, appraisal systems, promotions, and training.
We do not accept unsolicited resumes from search firms or staffing agencies. Any resume submitted (a) without the prior written approval from the Head of Recruiting or (b) to anyone at the Firm other than the Head of Recruiting will be deemed unsolicited. The Firm will not be obligated to pay any fee, commission, or other compensation in connection with any such submission, regardless of any prior communications or agency terms. Only agencies formally engaged by the Head of Recruiting for a specific search may submit candidates for consideration. Thank you for respecting our recruiting process.